Insulin resistance: A chicken that has come to roost

Annals of the New York Academy of Sciences

Volumn 892, Issue , 1999, Pages 45-57

  Reaven, Gerald M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Shaman Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

CONFERENCE PAPER; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

EID: 0032786924     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07784.x     Document Type: Conference Paper

References (57)

1. 1. Hollenbeck, C. B. & G. M. Reaven. 1987. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J. Clin. Endocrinol. Metab. 64: 1169-1173.
2. 2. Reaven, G. M., R. J. Brand, Y.-D. I. Chen, A. K. Mathur & L. Goldfine. 1993. Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes 42: 1324-1332.
3. 3. Reaven, G. M. 1998. Role of insulin resistance in human disease. Diabetes 37: 1594-1607.
4. 4. Reaven, G. M. 1995. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75: 473-486.
5. 5. Reaven, G. M. & R. Miller. 1968. Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes 17: 560-569.
6. 6. Shen, S. W., G. M. Reaven & J. W. Farquhar. 1970. Comparison of impedance to insulin-mediated glucose uptake in normal and diabetic subjects. J. Clin. Invest. 49: 2151-2160.
7. 7. Ginsberg, H., G. Kimmerling, J. M. Olefsky & G. M. Reaven. 1975. Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J. Clin. Invest. 55: 454-461.
8. 8. Sicree, R. A., P. Z. Zimmet, H. O. M. King & J. S. Coventry. 1987. Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 yr. Diabetes 36: 179-186.
9. 9. Warram, J. H., B. C. Martin, A. S. Krolewski, J. S. Soeldner & C. R. Kahn. 1990. Slow glucose removal rate and hyperinsulinemia precede the development of type 2 diabetes in the offspring of diabetic parents. Ann. Intern. Med. 113: 909-915.
10. 10. Haffner, S. M., M. P. Stern, B. D. Mitchell, H. P. Hazuda & J. K. Patterson. 1990. Incidence of type 2 diabetes in Mexican-Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39: 283-288.
11. 11. Lillioja, S., D. M. Mott, M. Spraul, et al. 1993. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent-diabetes mellitus. N. Engl. J. Med. 329: 1988-1992.
12. 12. Welborn, T. A., A. Breckenridge, A. H. Rubinstein, C. T. Dollery & T. R. Fraser. 1966. Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet 1: 1136-1137.
13. 13. Ferrannini, E., G. Buzzigoli & R. Bonadona. 1987. Insulin resistance in essential hypertension. N. Engl. J. Med. 317: 350-357.
14. 14. Shen, D.-C., S.-M. Shieh, M. Fuh, D.-A. Wu, Y.-D. I. Chen & G. M. Reaven. 1988. Resistance to insulin-stimulated glucose uptake in patients with hypertension. J. Clin. Endocrinol. Metab. 66: 580-583.
15. 15. Swislocki, A. L. M., B. B. Hoffman & G. M. Reaven. 1989. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am. J. Hypertens. 2: 419-423.
16. 16. Pollare, T., H. Lithell & C. Berne. 1990. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 39: 167-174.
17. 17. Zavaroni, I., S. Mazza, E. Dall'Aglio, P. Gasparini, M. Passeri & G. M. Reaven. 1992. Prevalence of hyperinsulinaemia in patients with high blood pressure. J. Intern. Med. 231: 235-240.
18. 18. Lucas, C. P., J. A. Estigarribia, L. L. Darga & G. M. Reaven. 1985. Insulin and blood pressure in obesity. Hypertension 7: 702-706.
19. 19. Modan, M., H. Halkin, S. Almog, et al. 1985. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J. Clin. Invest. 75: 809-817.
20. 20. Manicardi, V., L. Camellini, G. Bellodi, C. Caselli & E. Ferrannini. 1986. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J. Clin. Endocrinol. Metab. 62: 1302-1304.
21. 21. Fournier, A. M., M. T. Gadia, D. B. Kubrusly, J. S. Skylar & J. M. Sosenko. 1986. Blood pressure, insulin, and glycemia in nondiabetic subjects. Am. J. Med. 80: 861-864.
22. 22. Denker, P. S. & V. E. Pollok. 1992. Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch. Intern. Med. 152: 1649-1651.
23. 23. Ferrannini, E., A. Natali, B. Capaldo, M. Lehtovirta, S. Jacob & H. Yki-Järvinen, for the European Group for the Study of Insulin Resistance (EGIR). 1992. Insulin resistance, hyperinsulinemia, and blood pressure. Role of age and obesity. Hypertension 30: 1144-1149.
24. 24. Marigliano, A., R. Tedde, L. A. Sechi, A. Para, G. Pisanu & A. Pacifico. 1990. Insulinemia and blood pressure: relationships in patients with primary and secondary hypertension, and with or without glucose metabolism impairment. Am. J. Hypertens. 3: 521-526.
25. 25. Shamiss, A., J. Carroll & T. Rosenthal. 1992. Insulin resistance in secondary hypertension. Am. J. Hypertens. 5: 26-28.
26. 26. Ferrari, P., P. Weidmann, S. Shaw, D. Giachino, W. Riesen, Y. Allemann & G. Heynen. 1992. Altered insulin sensitivity, hyperinsulinemia and dyslipidemia in individuals with a family history of hypertension. Am. J. Hypertens. 5: 694-699.
27. 27. Facchini, F., Y.-D. I. Chen, C. Clinkingbeard, J. Jeppesen & G. M. Reaven. 1992. Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am. J. Hypertens. 5: 694-699.
28. 28. Allemann, Y., F. F. Horber, M. Colombo, P. Ferrari, S. Shaw, P. Jaeger & P. Weidman. 1993. Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet 341: 327-331.
29. 29. Ohno, Y., H. Suzuki, H. Yamakawa, M. Nakamura, K. Otsuka & T. Saruta. 1993. Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensive: possible role of disturbed calcium metabolism. J. Hypertens. 11: 421-426.
30. 30. Beatty, O. L., R. Harper, B. Sheridan, A. B. Atkinson & P. M. Bell. 1993. Insulin resistance in offspring of hypertensive parents. BMJ 307: 92-96.
31. 31. Skarfors, E. T., H. O. Lithell & I. Selinus. 1991. Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. J. Hypertens. 9: 217-223.
32. 32. Lissner, L., C. Bengtsson, L. Lapidus, K. Kristjansson & H. Wedel. 1992. Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 20: 797-801.
33. 33. Schmidt, M. I., F. L. Brancati, B. B. Duncan, G. H. Heiss, R. L. Watson & A. R. Sharrett. 1996. A metabolic syndrome in Whites and African-Americans: the atherosclerosis risk in communities baseline study. Diabetes Care 19: 414-419.
34. 34. Taittonen, L., M. Uhari, M. Nuutinen, J. Turtinen, T. Pokka & H. K. Akerblom. 1996. Insulin and blood pressure among healthy children. Am. J. Hypertens. 9: 193-199.
35. 35. Howard, G., D. H. O'Leary, D. Zaccaro, et al. 1996. Insulin sensitivity and atherosclerosis. Circulation 93: 1809-1817.
36. 36. Shinozaki, K., Y. Hattori, M. Suzuki, et al. 1997. Insulin resistance as an independent risk factor for carotid artery wall intima media thickening in vasospastic angina. Arterioscler. Thromb. Vasc. Biol. 17: 3302-3310.
37. 37. Yip, J., F. S. Facchini & G. M. Reaven. 1998. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J. Clin. Endocrinol. Metab. 83: 2773-2776.
38. 38. Neel, J. V. 1962. Diabetes mellitus: "a thrifty" genotype rendered detrimental by "progress"? Am. J. Hum. Genet. 14: 353-362.
39. 39. Cahill, G. F., Jr., M. G. Herrera, A. P. Morgan, et al. 1996. Hormone-fuel interrelationships during fasting. J. Clin. Invest. 45: 1751-1769.
40. 40. Cahill, G. F., Jr. & O. E. Owen. 1967. Starvation and survival. Trans. Am. Clin. Climat. Assoc. 79: 13-20.
41. 41. Owen, O. E., A. P. Morgan, H. G. Kemp, et al. 1967. Brain metabolism during fasting. J. Clin. Invest. 46: 1589-1597.
42. 42. Owen, O. E., P. Felig, A. P. Morgan, J. Wahren & G. F. Cahill, Jr. 1969. Liver and kidney metabolism during prolonged starvation. J. Clin. Invest. 48: 574-583.
43. 43. Eriksson, J., A. Franssila-Kallunki, A. Ekstrand, et al. 1989. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 321: 337-343.
44. 44. Ho, L. T., Z. Y. Chang, J. T. Wang, et al. 1990. Insulin insensitivity in offspring of parents with type 2 diabetes mellitus. Diabetic Med. 7: 31-34.
45. 45. Haffner, S. M., H. Miettinen, S. P. Gaskill & M. P. Stern. 1996. Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 39: 1201-1207.
46. 46. Bogardus, C., S. Lillioja, D. M. Mott, C. Hollenbeck & G. M. Reaven. 1985.Relationship between degree of obesity and in vivo insulin actin in man. Am. J. Physiol. 248: E286-E291.
47. 47. Lillioja, S., D. M. Mott, J. K. Zawadzki, et al. 1987. In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 36: 1329-1335.
48. 48. Martin, B. C., J. H. Warram, B. Rosner, et al. 1992. Familial clustering of insulin sensitivity. Diabetes 41: 850-854.
49. 49. Haffner, S. M., G. Howard, E. Mayer, et al. 1997. Insulin sensitivity and acute insulin response in african-americans, non-hispanic whites, and hispanics with NIDDM. Diabetes 46: 63-69.
50. 50. Aguirre, M. A., C. N. O. Jones, D. Pei, M. L. Villa & G. M. Reaven. 1997. Ethnic differences in insulin resistance and its consequences in older Mexican American and non-Hispanic White women. J. Gerontol. 52A: M56-M60.
51. 51. Laws, A., J. L. Jeppesen, P. C. Maheux, P. Schaaf, Y.-D. I. Chen & G. M. Reaven. 1994. Resistance to insulin-stimulated glucose uptake and dyslipidemia in Asian Indians. Arterioscler. Thromb. 14: 917-922.
52. 52. Collins, R., R. Peto, S. MacMahon, P. Herber, N. H. Fiebach, K. A. Eberlein, J. Godwin, N. Qizilbash, J. O. Taylor & C. H. Hennekens. 1990. Blood pressure, stroke and coronary heart disease. Pt. 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335: 827-838.
53. 53. Fuh, M. M.-T., S.-M. Shieh, D.-A. Wu, Y.-D. I. Chen & G. M. Reaven. 1987. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch. Int. Med. 147: 1035-1038.
54. 54. Sheu, W. H.-H., C.-Y. Jeng, S.-M. Shieh, D. D. Shen, Y.-D. I. Chen & G. M. Reaven. 1992. Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Am. J. Hypertens. 5: 444-448.
55. 55. Chen, N.-G., F. Abbasi, Y.-D. I. Chen, J. P. Cooke, P. S. Tsao & G. M. Reaven. 1998. Adherence of mononuclear cells to endothelium is increased in patients with hypertension. J. Invest. Med. 46: 108A.
56. 56. Ross, R. 1986. The pathogenesis of atherosclerosis. N. Engl. J. Med. 314: 488-500.
57. 57. Greaven, G. R. 1998. Hypothesis: muscle insulin resistance is the ("not-so") thrifty genotype. Diabetologia 41: 482-484.